Skip to main content
. 2020 Nov 20;11:590877. doi: 10.3389/fmicb.2020.590877

TABLE 2.

Common symptoms of GSM.

Common symptoms Non-treated group (n = 50)
MHT group (n = 50)
P-values
Asymptomatic Mild Moderate Severe Extremely severe Mean ± SD (Mean) Asymptomatic Mild Moderate Severe Extremely severe Mean ± SD (Mean)
Vulvovaginal symptom 2.32 ± 0.36 (2) 1.06 ± 0.18 (1) < 0.01
Dryness 30.00% 36.00% 20.00% 10.00% 4.00% 1.22 ± 0.16 (1) 58.00% 26.00% 16.00% 0.00% 0.00% 0.58 ± 0.11 (0) <0.005
Itching 62.00% 20.00% 6.00% 12.00% 0.00% 0.68 ± 0.15 (0) 68.00% 22.00% 10.00% 0.00% 0.00% 0.42 ± 0.10 (0) 0.366
Burning 78.00% 10.00% 4.00% 8.00% 0.00% 0.42 ± 0.13 (0) 96.00% 2.00% 2.00% 0.00% 0.00% 0.06 ± 0.04 (0) < 0.01
Urological symptom 0.94 ± 0.19 (0) 0.52 ± 0.16 (0) 0.051
Frequent, urgent, and painful urination 70.00% 18.00% 10.00% 2.00% 0.00% 0.44 ± 0.11 (0) 84.00% 14.00% 2.00% 0.00% 0.00% 0.18 ± 0.06 (0) 0.072
Recurrent urinary tract infection 90.00% 2.00% 8.00% 0.00% 0.00% 0.18 ± 0.08 (0) 96.00% 0.00% 4.00% 0.00% 0.00% 0.08 ± 0.06 (0) 0.436
Incontinence 74.00% 20.00% 6.00% 0.00% 0.00% 0.32 ± 0.08 (0) 84.00% 10.00% 2.00% 4.00% 0.00% 0.26 ± 0.10 (0) 0.305
Sexual symptom 2.58 ± 0.17 (3) 1.62 ± 0.20 (1) < 0.005
Decreased libido 8.00% 8.00% 32.00% 22.00% 30.00% 2.58 ± 0.17 (3) 77.80% 24.00% 20.00% 14.00% 14.00% 1.62 ± 0.20 (1) <0.005
GSM 5.84 ± 0.49 (5) 3.20 ± 0.41 (2.5) < 0.005

P-value in bold indicates statistical difference is significant.